Form 4 holding
10%+ Owner
Monte Rosa Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 7,692,298
- Estimated value
- $146,153,662
- Report date
- 28 Jun 2021
- Price
- $19.00
- Ownership
- Indirect
Forest Baskett
Insider Reports History
- Reporting-owner location
- Menlo Park, CA
- Latest reporting-owner signature
- /s/ Zachary Bambach, attorney-in-fact
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Forest Baskett
Form 4 holding
10%+ Owner
Savara Inc
- Security class
- Common Stock
- Shares / value
- 24,471,264
- Estimated value
- $108,897,125
- Report date
- 17 Jul 2023
- Price
- $4.45
- Ownership
- Indirect
Form 4 holding
10%+ Owner
MBX Biosciences, Inc.
- Security class
- Common Stock
- Shares / value
- 3,614,486
- Estimated value
- $38,638,855
- Report date
- 16 Sep 2024
- Price
- $10.69
- Ownership
- Indirect
Form 4 holding
10%+ Owner
SpyGlass Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 1,357,263
- Estimated value
- $37,772,629
- Report date
- 09 Feb 2026
- Price
- $27.83
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Trevi Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 12,273,280
- Estimated value
- $16,814,393
- Report date
- 17 Apr 2025
- Price
- $1.37
- Ownership
- Indirect
Form 4 holding
10%+ Owner
ARDELYX, INC.
- Security class
- Common Stock
- Shares / value
- 2,258,850
- Estimated value
- $14,998,764
- Report date
- 15 Dec 2021
- Price
- $6.64
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Korro Bio, Inc.
- Security class
- Common Stock
- Shares / value
- 1,297,893
- Estimated value
- $14,419,591
- Report date
- 10 Mar 2026
- Price
- $11.11
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Coursera, Inc.
- Security class
- Common Stock
- Shares / value
- 100,420
- Estimated value
- $1,846,623
- Report date
- 15 Feb 2023
- Price
- $18.39
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Metacrine, Inc.
- Security class
- Common Stock
- Shares / value
- 2,563,257
- Estimated value
- $1,204,731
- Report date
- 22 Dec 2021
- Price
- $0.4700
- Ownership
- Indirect
Form 4 holding
Director
Robinhood Markets, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 36,688
- Estimated value
- $450,661
- Report date
- 02 May 2022
- Price
- $12.28
- Ownership
- Indirect
Form 4 holding
10%+ Owner
IonQ, Inc.
- Security class
- Common Stock
- Shares / value
- 9,525
- Estimated value
- $125,856
- Report date
- 16 Nov 2022
- Price
- $13.21
- Ownership
- Indirect
Form 4 holding
10%+ Owner
AVEO PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 3,220
- Estimated value
- $48,300
- Report date
- 19 Oct 2022
- Price
- $15.00
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Sagimet Biosciences Inc.
- Security class
- Series A Common Stock
- Shares / value
- 11,300
- Estimated value
- $46,330
- Report date
- 29 Jan 2024
- Price
- $4.10
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Mirum Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 1,548
- Estimated value
- $43,398
- Report date
- 13 Jun 2023
- Price
- $28.04
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Desktop Metal, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 7,333
- Estimated value
- $5,377
- Report date
- 08 Jun 2021
- Price
- $0.7332
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Eargo, Inc.
- Security class
- Common Stock
- Shares / value
- 1,629
- Estimated value
- $4,219
- Report date
- 24 May 2021
- Price
- $2.59
- Ownership
- Indirect
Form 4 holding
Director, 10%+ Owner
NeueHealth, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 02 Oct 2025
- Price
- $6.84
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Korro Bio, Inc.
- Security class
- Pre-Funded Warrants
- Shares / value
- 242,945
- Estimated value
- Report date
- 10 Mar 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Akouos, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 30 Nov 2022
- Price
- $12.50
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Arcellx, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 22 Dec 2022
- Price
- $55.27
- Ownership
- Indirect
Form 4 holding
10%+ Owner
GENOCEA BIOSCIENCES, INC.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 25 May 2022
- Price
- $1.25
- Ownership
- Indirect
Form 4 holding
10%+ Owner
MBX Biosciences, Inc.
- Security class
- Series A Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
MBX Biosciences, Inc.
- Security class
- Series B Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 16 Sep 2024
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Monte Rosa Therapeutics, Inc.
- Security class
- Series A-2 convertible preferred stock
- Shares / value
- 0
- Estimated value
- Report date
- 28 Jun 2021
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Monte Rosa Therapeutics, Inc.
- Security class
- Series B convertible preferred stock
- Shares / value
- 0
- Estimated value
- Report date
- 28 Jun 2021
- Price
- $2.00
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Monte Rosa Therapeutics, Inc.
- Security class
- Series C convertible preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 28 Jun 2021
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
NeueHealth, Inc.
- Security class
- Series A Convertible Perpetual Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Oct 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
NeueHealth, Inc.
- Security class
- Series B Convertible Perpetual Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Oct 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, 10%+ Owner
NeueHealth, Inc.
- Security class
- Warrant (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 02 Oct 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
SpyGlass Pharma, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Feb 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
SpyGlass Pharma, Inc.
- Security class
- Series B Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Feb 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
SpyGlass Pharma, Inc.
- Security class
- Series C-1 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Feb 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
SpyGlass Pharma, Inc.
- Security class
- Series C-2 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Feb 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
SpyGlass Pharma, Inc.
- Security class
- Series D Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Feb 2026
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Trevi Therapeutics, Inc.
- Security class
- 3.5-Year Common Stock Warrant
- Shares / value
- 0
- Estimated value
- Report date
- 17 Apr 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Forest Baskett
4
KRRO
Korro Bio, Inc.
- Report period
- 10 Mar 2026
- Transactions
- 2
- Transaction value
- +$2,300,881
- Accepted by SEC
- 12 Mar 2026, 20:15
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SGP
SpyGlass Pharma, Inc.
- Report period
- 09 Feb 2026
- Transactions
- 13
- Transaction value
- +$15,000,000
- Accepted by SEC
- 11 Feb 2026, 16:30
- Role
- 10%+ Owner
- Next action
- Open filing details
3
SGP
SpyGlass Pharma, Inc.
- Report period
- 05 Feb 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 05 Feb 2026, 16:05
- Role
- 10%+ Owner
- Next action
- Open filing details
5
TRVI
Trevi Therapeutics, Inc.
- Report period
- 31 Dec 2025
- Transactions
- 2
- Transaction value
- +$2,537,037
- Accepted by SEC
- 13 Feb 2026, 16:30
- Role
- 10%+ Owner
- Next action
- Open filing details
4
NEUE
NeueHealth, Inc.
- Report period
- 02 Oct 2025
- Transactions
- 27
- Transaction value
- +$10.15
- Accepted by SEC
- 06 Oct 2025, 17:50
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
NEUE
NeueHealth, Inc.
- Report period
- 01 Oct 2024
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 03 Oct 2024, 18:20
- Role
- 10%+ Owner
- Next action
- Open filing details
4
MBX
MBX Biosciences, Inc.
- Report period
- 16 Sep 2024
- Transactions
- 5
- Transaction value
- +$8,000,000
- Accepted by SEC
- 17 Sep 2024, 20:26
- Role
- 10%+ Owner
- Next action
- Open filing details
3
MBX
MBX Biosciences, Inc.
- Report period
- 12 Sep 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Sep 2024, 19:22
- Role
- 10%+ Owner
- Next action
- Open filing details
4
KRRO
Korro Bio, Inc.
- Report period
- 22 Apr 2024
- Transactions
- 1
- Transaction value
- +$999,992
- Accepted by SEC
- 24 Apr 2024, 17:00
- Role
- 10%+ Owner
- Next action
- Open filing details
4
NEUE
NeueHealth, Inc.
- Report period
- 08 Apr 2024
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 10 Apr 2024, 18:54
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SGMT
Sagimet Biosciences Inc.
- Report period
- 29 Jan 2024
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 31 Jan 2024, 16:57
- Role
- 10%+ Owner
- Next action
- Open filing details
3
KRRO
Korro Bio, Inc.
- Report period
- 03 Nov 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 07 Nov 2023, 21:27
- Role
- 10%+ Owner
- Next action
- Open filing details
4
NEUE
Bright Health Group Inc.
- Report period
- 31 Oct 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 02 Nov 2023, 18:30
- Role
- 10%+ Owner
- Next action
- Open filing details
4
SVRA
Savara Inc
- Report period
- 17 Jul 2023
- Transactions
- 1
- Transaction value
- +$999,999
- Accepted by SEC
- 19 Jul 2023, 19:05
- Role
- 10%+ Owner
- Next action
- Open filing details
4
MIRM
Mirum Pharmaceuticals, Inc.
- Report period
- 13 Jun 2023
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 15 Jun 2023, 16:26
- Role
- 10%+ Owner
- Next action
- Open filing details
4
COUR
Coursera, Inc.
- Report period
- 15 Feb 2023
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 17 Feb 2023, 17:54
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ACLX
Arcellx, Inc.
- Report period
- 20 Dec 2022
- Transactions
- 5
- Transaction value
- -$51,207
- Accepted by SEC
- 22 Dec 2022, 17:25
- Role
- 10%+ Owner
- Next action
- Open filing details
4
Akouos, Inc.
- Report period
- 30 Nov 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 02 Dec 2022, 16:02
- Role
- 10%+ Owner
- Next action
- Open filing details
4
IONQ
IonQ, Inc.
- Report period
- 16 Nov 2022
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 18 Nov 2022, 16:13
- Role
- 10%+ Owner
- Next action
- Open filing details
4
AVEO PHARMACEUTICALS, INC.
- Report period
- 19 Oct 2022
- Transactions
- 6
- Transaction value
- $0
- Accepted by SEC
- 21 Oct 2022, 16:48
- Role
- 10%+ Owner
- Next action
- Open filing details
4
NEUE
Bright Health Group Inc.
- Report period
- 17 Oct 2022
- Transactions
- 1
- Transaction value
- +$37,700,000
- Accepted by SEC
- 19 Oct 2022, 19:51
- Role
- 10%+ Owner
- Next action
- Open filing details
4
GENOCEA BIOSCIENCES, INC.
- Report period
- 24 May 2022
- Transactions
- 2
- Transaction value
- -$750,662
- Accepted by SEC
- 26 May 2022, 18:16
- Role
- 10%+ Owner
- Next action
- Open filing details
4
HOOD
Robinhood Markets, Inc.
- Report period
- 02 May 2022
- Transactions
- 7
- Transaction value
- $0
- Accepted by SEC
- 04 May 2022, 19:39
- Role
- Director
- Next action
- Open filing details
4
TRVI
Trevi Therapeutics, Inc.
- Report period
- 11 Apr 2022
- Transactions
- 1
- Transaction value
- +$4,999,998
- Accepted by SEC
- 13 Apr 2022, 17:04
- Role
- 10%+ Owner
- Next action
- Open filing details
4
HOOD
Robinhood Markets, Inc.
- Report period
- 28 Jan 2022
- Transactions
- 9
- Transaction value
- -$29,598
- Accepted by SEC
- 01 Feb 2022, 18:17
- Role
- Director
- Next action
- Open filing details
4
NEUE
Bright Health Group Inc.
- Report period
- 03 Jan 2022
- Transactions
- 1
- Transaction value
- +$75,000,000
- Accepted by SEC
- 05 Jan 2022, 16:46
- Role
- 10%+ Owner
- Next action
- Open filing details
4
Metacrine, Inc.
- Report period
- 10 Dec 2021
- Transactions
- 3
- Transaction value
- -$494,483
- Accepted by SEC
- 27 Dec 2021, 15:41
- Role
- 10%+ Owner
- Next action
- Open filing details
4
ARDX
ARDELYX, INC.
- Report period
- 09 Dec 2021
- Transactions
- 8
- Transaction value
- -$3,642,572
- Accepted by SEC
- 27 Dec 2021, 16:40
- Role
- 10%+ Owner
- Next action
- Open filing details
4
HOOD
Robinhood Markets, Inc.
- Report period
- 10 Nov 2021
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 12 Nov 2021, 15:36
- Role
- Director
- Next action
- Open filing details
4
HOOD
Robinhood Markets, Inc.
- Report period
- 27 Oct 2021
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 29 Oct 2021, 17:11
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
TRVI
Trevi Therapeutics, Inc.
- Report period
- 18 Oct 2021
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 19 Oct 2021, 21:10
- Role
- 10%+ Owner
- Next action
- Open filing details
4
COUR
Coursera, Inc.
- Report period
- 11 Aug 2021
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 13 Aug 2021, 16:31
- Role
- 10%+ Owner
- Next action
- Open filing details
4
HOOD
Robinhood Markets, Inc.
- Report period
- 02 Aug 2021
- Transactions
- 20
- Transaction value
- +$77,118,720
- Accepted by SEC
- 03 Aug 2021, 17:47
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
3
HOOD
Robinhood Markets, Inc.
- Report period
- 29 Jul 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 29 Jul 2021, 17:50
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
4
NEUE
Bright Health Group Inc.
- Report period
- 28 Jun 2021
- Transactions
- 22
- Transaction value
- +$34,999,992
- Accepted by SEC
- 30 Jun 2021, 21:28
- Role
- 10%+ Owner
- Next action
- Open filing details
4
GLUE
Monte Rosa Therapeutics, Inc.
- Report period
- 28 Jun 2021
- Transactions
- 7
- Transaction value
- +$19,950,000
- Accepted by SEC
- 30 Jun 2021, 18:00
- Role
- 10%+ Owner
- Next action
- Open filing details
3
NEUE
Bright Health Group Inc.
- Report period
- 24 Jun 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 24 Jun 2021, 21:23
- Role
- 10%+ Owner
- Next action
- Open filing details
3
GLUE
Monte Rosa Therapeutics, Inc.
- Report period
- 23 Jun 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 23 Jun 2021, 21:01
- Role
- 10%+ Owner
- Next action
- Open filing details
4
DM
Desktop Metal, Inc.
- Report period
- 08 Jun 2021
- Transactions
- 5
- Transaction value
- $0
- Accepted by SEC
- 10 Jun 2021, 16:38
- Role
- 10%+ Owner
- Next action
- Open filing details
4
Eargo, Inc.
- Report period
- 24 May 2021
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 26 May 2021, 16:34
- Role
- 10%+ Owner
- Next action
- Open filing details
4
COUR
Coursera, Inc.
- Report period
- 19 May 2021
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 21 May 2021, 17:00
- Role
- 10%+ Owner
- Next action
- Open filing details